PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV)

• Status: Completed
• Trial end date: 2017-09-11

Summary

The purpose of this study is to determine whether atazanavir powder combined with ritonavir is safe and well tolerated and produces appropriate drug exposure in children ≥3 months to <6 years of age.

• Phase: Phase 3

Details

• Lead Sponsor: Bristol-Myers Squibb
• Treatments: Atazanavir Sulfate; Pharmaceutical Solutions; Ritonavir